United States · FDA National Drug Code directory
XELPROS
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 47335-317_44b8ddc0-81dc-4613-bbe8-0da960cc179c
- Product NDC
- 47335-317
- Form
- SOLUTION/ DROPS
- Composition / generic term
- latanoprost
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20180912
- Source listing expiry
- 20261231
Source-listed ingredients
- LATANOPROST — .05 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, DROPPER in 1 BOX (47335-317-90) / 2.5 mL in 1 BOTTLE, DROPPER · 47335-317-90
- 3 BOTTLE, DROPPER in 1 BOX (47335-317-92) / 2.5 mL in 1 BOTTLE, DROPPER · 47335-317-92
- 3 BOTTLE, DROPPER in 1 BOX (47335-317-94) / 2.5 mL in 1 BOTTLE, DROPPER · 47335-317-94
- 1 BOTTLE, DROPPER in 1 BOX (47335-317-98) / 2.5 mL in 1 BOTTLE, DROPPER · 47335-317-98
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →